Circulating Tumor DNA as a Marker of Minimal Residual Disease.

Detalles Bibliográficos
Publicado en:Oncology (08909091) Vol. 36; no. 10; pp. 600 - 604
Autores principales: Fangman, Ben, Raghav, Kanwal, Kopetz, Scott
Formato: pictorial tables/charts Journal Article
Publicado: MJH Life Sciences Oct2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=159638471&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 159638471
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08909091
        YYT
      jtl: Oncology (08909091)
      issn: 08909091
      maglogo: N
    pubinfo:
      dt: Oct2022
      vid: 36
      iid: 10
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        159638471
        159638471
        159638471
        10.46883/2022.25920975
        159638471
      ppf: 600
      ppct: 4
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Circulating Tumor DNA as a Marker of Minimal Residual Disease.
      aug:
        au:
          Fangman, Ben
          Raghav, Kanwal
          Kopetz, Scott
        affil: Division of Cancer Medicine and Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center. Houston, TX
      sug:
        subj:
          Cell-Free Nucleic Acids
          DNA
          Tumor Markers, Biological
          Neoplastic Processes
          Colorectal Neoplasms Epidemiology
          Colorectal Neoplasms Mortality
          Cause of Death United States
          United States
          Decision Making, Clinical
      pubtype: Academic Journal
      doctype:
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N